These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 26670486)
1. Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells. Li Z; Li C; Zhou Y; Chen W; Luo G; Zhang Z; Wang H; Zhang Y; Xu D; Sheng P Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E355-66. PubMed ID: 26670486 [TBL] [Abstract][Full Text] [Related]
2. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440 [TBL] [Abstract][Full Text] [Related]
3. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961 [TBL] [Abstract][Full Text] [Related]
4. [Osteoclast differentiation of Raw264.7 cells expressing enhanced green fluorescent protein in vitro]. Pei Y; Lyu C; Liu H Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Apr; 50(4):235-9. PubMed ID: 26081961 [TBL] [Abstract][Full Text] [Related]
5. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts. Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029 [TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin influences the bone resorption activity of osteoclasts. Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320 [TBL] [Abstract][Full Text] [Related]
7. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855 [TBL] [Abstract][Full Text] [Related]
8. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430 [TBL] [Abstract][Full Text] [Related]
9. Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells. Zuo J; Jiang J; Dolce C; Holliday LS Biochem Biophys Res Commun; 2004 May; 318(1):162-7. PubMed ID: 15110768 [TBL] [Abstract][Full Text] [Related]
10. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328 [TBL] [Abstract][Full Text] [Related]
11. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411 [TBL] [Abstract][Full Text] [Related]
12. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation. Shim KS; Ma CJ; Kim DS; Ma JY J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017 [TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499 [TBL] [Abstract][Full Text] [Related]
14. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts. Kim MH; Ryu SY; Choi JS; Min YK; Kim SH J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230 [TBL] [Abstract][Full Text] [Related]
15. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor. Geng DC; Zhu XS; Mao HQ; Meng B; Chen L; Yang HL; Xu YZ J Biomed Mater Res A; 2011 Dec; 99(4):516-22. PubMed ID: 21913318 [TBL] [Abstract][Full Text] [Related]
16. Commercial Honeybush (Cyclopia spp.) Tea Extract Inhibits Osteoclast Formation and Bone Resorption in RAW264.7 Murine Macrophages-An in vitro Study. Visagie A; Kasonga A; Deepak V; Moosa S; Marais S; Kruger MC; Coetzee M Int J Environ Res Public Health; 2015 Oct; 12(11):13779-93. PubMed ID: 26516894 [TBL] [Abstract][Full Text] [Related]
17. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis. Gong W; Dou H; Liu X; Sun L; Hou Y Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352 [TBL] [Abstract][Full Text] [Related]
20. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Kanno S; Hirano S; Kayama F Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]